1.Advances in researches on the relationship between prostatic diseases and erectile dysfunction.
National Journal of Andrology 2005;11(6):462-465
Prostatic diseases and erectile dysfunction (ED) are common diseases in urology and andrology. Basic and clinical studies have proved that there is a close relationship between the two. This article reviews the mechanism, diagnosis and treatment of ED caused by several prostatic diseases, such as acute prostatitis, chronic prostatitis, benign prostate hyperplasia and prostate cancer.
Chronic Disease
;
Erectile Dysfunction
;
diagnosis
;
etiology
;
therapy
;
Humans
;
Male
;
Prostatic Diseases
;
complications
;
Prostatic Hyperplasia
;
complications
;
Prostatic Neoplasms
;
complications
;
Prostatitis
;
complications
2.A case of nephrogenic diabetes insipidus caused by obstructive uropathy due to prostate cancer.
Eun Gyoung HONG ; YuJin SUH ; Yoon Sok CHUNG ; Hyeon Man KIM ; Gyu Tae SHIN ; Do Young CHUNG ; Rae Woong PARK
Yonsei Medical Journal 2000;41(1):150-154
Nephrogenic diabetes insipidus (DI) secondary to chronic urinary tract obstruction is a rare disease. The exact cause is unknown but it is likely that increased collecting duct pressures cause damage to the tubular epithelium, resulting in insensitivity to the action of arginine-vasopressin (AVP). A 77-year-old man complaining of polyuria and polydipsia was treated with alpha glucosidase inhibitor under the impression of polyuria due to diabetes mellitus. But his symptoms did not improve. Water deprivation and AVP administration study revealed that the patient had nephrogenic DI. Urinary tract obstruction due to an enlarged prostate was suggested as a principal cause of nephrogenic DI. The patient underwent transurethral resection of the prostate and bilateral subcapsular orchiectomy. After surgery, the urine osmolarity was normalized and the patient became symptom-free. We report a case of nephrogenic DI due to obstructive uropathy which was cured by surgery eliminating obstruction.
Adenocarcinoma/ultrasonography
;
Adenocarcinoma/radionuclide imaging
;
Adenocarcinoma/pathology
;
Adenocarcinoma/complications*
;
Aged
;
Case Report
;
Constriction, Pathologic/etiology
;
Diabetes Insipidus, Nephrogenic/etiology*
;
Human
;
Male
;
Prostatic Neoplasms/ultrasonography
;
Prostatic Neoplasms/radionuclide imaging
;
Prostatic Neoplasms/pathology
;
Prostatic Neoplasms/complications*
;
Urologic Diseases/etiology*
3.Localized amyloidosis of seminal vesicle and vas deferens: Report of Two Cases.
Sun Young JUN ; Kyu Rae KIM ; Kyoung Sik CHO ; Jae Y RO
Journal of Korean Medical Science 2003;18(3):447-451
We reported localized amyloidosis involving seminal vesicles and vasa deferentia, which was found in two patients with prostatic adenocarcinoma. A 60-yr-old (Case 1) and a 59-yr-old (Case 2) man came to our hospital with elevation of serum prostate-specific antigen (PSA) and biopsy proven carcinoma, respectively. MRI revealed multiple irregular foci of low signal intensity in the prostates as well as in both seminal vesicles and vasa deferentia on T2-weighted imaging, suggesting prostatic carcinoma with extension to both seminal vesicles and vasa deferentia in both cases. Under the clinical diagnosis of stage III prostatic adenocarcinoma, a radical prostatectomy was performed in both patients. Microscopically, Gleason score 7 adenocarcinoma was observed in both patients. In addition, isolated amyloidosis of both seminal vesicles and vasa deferentia was found without carcinoma involvement. Localized amyloidosis in the seminal vesicles, which is considered as senile process, has been occasionally reported in the autopsy and in the surgical specimens. Amyloid deposition in the vas deferens has also been reported in the literature, however, the deposition mimicking extension of carcinoma has not been reported. In this report, two cases of isolated amyloidosis of the seminal vesicles and vasa deferentia are described with electron microscopic study and literature review.
Adenocarcinoma/complications
;
Amyloidosis/complications/*pathology
;
Human
;
Male
;
Middle Aged
;
Prostatic Neoplasms/complications
;
Seminal Vesicles/*pathology
;
Vas Deferens/*pathology
4.Synchronous primary carcinomas of the bladder and prostate.
Sheng-Hui LEE ; Phei-Lang CHANG ; Shao-Ming CHEN ; Guang-Huan SUN ; Chien-Lun CHEN ; Biing-Yir SHEN ; Ya-Shen WU ; Ke-Hung TSUI
Asian Journal of Andrology 2006;8(3):357-359
AIMTo determine the incidence of adenocarcinoma of the prostate for patients undergoing radical cystoprostatectomy for bladder cancer in Taiwan.
METHODSA total of 248 patients in Taiwan who were histologically confirmed for transitional cell carcinoma of the bladder underwent cystoprostatectomy. Histopathologic evaluation of the prostate specimens sectioned at 5 mm intervals was performed.
RESULTSOf the 248 patients, 10 (4.03%) were found to have prostate cancer. Of the 10 cases of unsuspected prostate cancer, eight proved to be at stage T1 or T2, and two at T3 and T4, respectively. This rate of incidentally found prostate cancer amongst our bladder cancer patients appeared to be lower than that found in bladder cancer patients in similar studies in USA.
CONCLUSIONAlthough the incidence of incidental prostate cancer in patients in Taiwan with bladder cancer is not high compared with that in Western countries, we suggest that digital rectal examination and prostate-specific antigen (PSA) are important screening tools for men with bladder cancer, especially for those aged 60 years and older in Taiwan.
Carcinoma, Transitional Cell ; pathology ; surgery ; Humans ; Male ; Neoplasm Staging ; Prostatectomy ; Prostatic Neoplasms ; complications ; surgery ; Urinary Bladder Neoplasms ; complications ; pathology ; surgery
5.Influence of histological prostatitis on the clinical features of benign prostatic hyperplasia and prostate cancer.
Feng ZHANG ; A SI-MU-JIANG-ABULA ; Li-Dong ZHANG
National Journal of Andrology 2014;20(4):354-358
OBJECTIVETo investigate the influence of histological prostatitis (HP) on the clinical features of benign prostatic hyperplasia (BPH) and prostate cancer (PCa) and its clinical significance.
METHODSWe retrospectively studied the data of 273 cases of BPH and 240 cases of PCa, including age, prostate volume, total prostatic special antigen (tPSA), prostatic special antigen density (PSAD), maximum urinary flow rate (MFR) and acute urinary retention (AUR).
RESULTSTotally, 186 cases of BPH (68.13%) and 45 cases of PCa (18.75%) were complicated by HP, with statistically significant difference between the two groups (P < 0.05). Compared with the patients with BPH only, those complicated by HP showed significantly elevated tPSA, PSAD and total prostate volume (all P < 0.05), decreased MFR (P < 0.05) and increased risk of AUR (P < 0.05). There was no significant difference in the patients' age between the two groups (P > 0.05). The levels of tPSA and PSAD were remarkably higher in the PCa patients complicated by HP than in those with PCa only (all P < 0.05), but no significant differences were found in the other indexes between the two groups (P > 0.05).
CONCLUSIONHP may play a certain role in the progenesis and progression of HP and PCa, but HP is associated more closely with BPH.
Aged ; Disease Progression ; Humans ; Male ; Organ Size ; Prostate ; pathology ; Prostate-Specific Antigen ; blood ; Prostatic Hyperplasia ; etiology ; Prostatic Neoplasms ; complications ; Prostatitis ; complications ; Retrospective Studies ; Urinary Retention ; etiology
6.Review of anesthesia for robotic-assisted radical prostatectomy: in comparison with radical retropubic prostatectomy.
Hyo Seok NA ; Hye Young KIM ; Sang Hwan DO ; Young Tae JEON ; Jung Won HWANG ; Ah Young OH
Anesthesia and Pain Medicine 2009;4(4):364-367
BACKGROUND: Robotic-assisted radical prostatectomy (RARP) using da Vinci(R) Surgical System is an emerging technique for management of prostate cancer. With retrospective chart review of patients who had RARP or radical retropubic prostatectomy (RRP), we tried to evaluate and compare the effects on the factors related to patients' outcomes. METHODS: We reviewed the data of 144 patients who underwent RARP (group R, n = 76) or RRP (group C, n = 68) under general anesthesia in the same time period retrospectively.The age, anesthesia time, transfusion rate, PACU time, administration of additional analgesics at PACU, admission day after the operation, postoperative complications and intraoperative PaCO2 were examined and compared. RESULTS: Group R showed significantly lower transfusion rate and more rapid discharge after the operation. Intraoperative PaCO2 was increased in process of time in group R. Other variables were not significantly different between the two groups.In group R, mild neuropathy occurred in 2 patients and subcutaneous emphysema occurred in 1 patient. CONCLUSION: Patients who had RARP needed significantly less transfusion during operation and significantly shorter admission time compared to patients who had RRP.
Analgesics
;
Anesthesia
;
Anesthesia, General
;
Humans
;
Postoperative Complications
;
Prostatectomy
;
Prostatic Neoplasms
;
Retrospective Studies
;
Subcutaneous Emphysema
7.Giant Multilocular Prostatic Cystadenoma Presenting with Obstructive Aspermia.
Jong Pil PARK ; Nam Hoon CHO ; Young Tack OH ; Young Deuk CHOI
Yonsei Medical Journal 2007;48(3):554-556
Giant multilocular prostatic cystadenoma (GMPC) is a rare benign tumor involving the prostate gland. Microscopically, it masquerades phyllodes tumor or transitional zone hyperplasia. We report one case of GMPC arising from the prostate central zone (CZ), presenting with long-standing aspermia associated with seminal vesicle fibrous obliteration.
Aspermia/etiology/*pathology
;
Cystadenoma/complications/*pathology
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Prostate/*pathology
;
Prostatic Neoplasms/complications/*pathology
8.Evaluation of perioperative complications in the elderly with radical prostatectomy.
Fang-ning WAN ; Yao ZHU ; Jia-quan ZHOU ; Ding-wei YE ; Xu-dong YAO ; Shi-lin ZHANG ; Bo DAI ; Hai-liang ZHANG
Chinese Journal of Surgery 2012;50(11):995-998
OBJECTIVETo evaluate the incidence and severity of perioperative complications in elderly patients with radical prostatectomy (RP).
METHODSA total of 242 patents underwent RP for prostate cancer were retrospectively assessed, whose clinicopathologic factors and perioperative complications were retrieved from the medical records. The mean age in the elderly group (n = 163) and control group (n = 79) were (73.2 ± 2.4) and (63.2 ± 4.8) years, respectively. The clinicopathologic factors including Charlson comorbidity index and preoperative prostate specific antigen were statistically significant different. The difference of clinicopathologic factors and perioperative complications between the elderly group (≥ 70 years old) and control group were statistically analyzed using the SPSS 17.0.
RESULTSThe incidence of perioperative complications was 23.5% in the elderly group and 22.7% in the control group. Except for gross hematuria (there were 12 cases in elderly group and 1 case in control group, respectively, χ(2) = 3.89, P < 0.05) and perioperative transfusion (there were 36 cases in elderly group and 7 cases in control group, respectively, χ(2) = 6.37, P < 0.05), there was no significant difference in each kind or total of perioperative complications.
CONCLUSIONThe elderly patients underwent RP in experienced center are not associated with higher or more serious perioperative complications.
Aged ; Humans ; Incidence ; Intraoperative Complications ; epidemiology ; Male ; Middle Aged ; Postoperative Complications ; epidemiology ; Prostatectomy ; Prostatic Neoplasms ; surgery ; Retrospective Studies
9.Endoluminal therapy for bilateral malignant ureteric obstruction.
Yong-Da LIU ; Jian YUAN ; Shun-Tan HUANG ; Jin-Tai LUO ; Guo-Hua ZENG ; Li XUN
Chinese Journal of Oncology 2007;29(9):717-719
OBJECTIVETo evaluate the endourological technique in the treatment of bilateral malignant ureteric obstruction.
METHODSThe data of 43 patients (totally, 70 cases) with bilateral malignant ureteric obstruction treated with endoluminal therapy were reviewed retrospectively. Of 70 cases, 38 were treated by retrograde double-J stenting, 24 by minimally invasive percutaneous nephrotomy (MPCN) and 8 by antegrade double-J stenting.
RESULTSAll patients were followed up for an average of 12 months. The retrograde double-J stenting, MPCN and antegrade double-J stenting was successfully performed in 50.0% (19/38), 100.0% (24/24) and 62.5% (5/8), respectively. Technical failures in placing retrograde double-J stent were too difficult to identify the ureteric orifice (13/38) or failing to cross the obstruction site because of severe extraluminal compression (6/38). Failure in placing antegrade double-J stent was due to severe extraluminal compression (3/8). Dislodgment of nephrostomy tubes (11/19) was the major factor which limited the application of MPCN.
CONCLUSIONIt is safe and effective to treat malignant ureteric obstruction with endourological technique, and suggested initially with retrograde double-J stenting. If malignant ureteric orifice occlusion or a severe extraluminal compression is showed in the imaging, MPCN or antegrade double-J stenting may be selected according to the site and the extent of obstruction.
Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Nephrostomy, Percutaneous ; methods ; Prostatic Neoplasms ; complications ; Retrospective Studies ; Stents ; Stomach Neoplasms ; complications ; Treatment Failure ; Treatment Outcome ; Ureteral Obstruction ; etiology ; surgery ; Urinary Bladder Neoplasms ; complications ; Uterine Cervical Neoplasms ; complications
10.Prostate cancer after prostatectomy for benign prostatic hyperplasia.
Lixin HUA ; Jiexiu ZHANG ; Hongfei WU ; Yuangeng SUI ; Wei ZHANG ; Lixin QIAN ; Zengjun WANG
National Journal of Andrology 2004;10(8):612-613
OBJECTIVETo study the diagnosis and treatment of prostate cancer after prostatectomy for benign prostatic hyperplasia (BPH).
METHODSTwelve cases of prostate cancer after prostatectomy for benign prostatic hyperplasia were reviewed and studied. The mean intervals between prostatectomy for BPH and the diagnosis of prostate cancer was 10 months to 14 years, 5.6 years on average. The main symptoms were dysuria, hematuria and pain. Serum prostate specific antigen (PSA) was elevated in 11 cases. Digital rectal examination (DRE) was abnormal in 8 cases. Three cases were in clinical stage B, 3 in stage C and 6 in stage D. Ten cases received combined androgen blockade therapy. Monotherapy with surgical castration was given to 2 cases. Three patients with urinary tract obstruction received additional treatment of TURP.
RESULTSDuring the 4 months to 8 years follow-up, 3 patients died, 6 remained stable and 2 deteriorated.
CONCLUSIONSurgery for BPH could not prevent the development of prostate cancer. PSA and DRE were the main methods for the diagnosis of this prostate cancer.
Aged ; Aged, 80 and over ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Postoperative Complications ; Prostate-Specific Antigen ; blood ; Prostatic Hyperplasia ; surgery ; Prostatic Neoplasms ; diagnosis ; Retrospective Studies ; Transurethral Resection of Prostate